KimAChongBF.Photosensitivity in cutaneous lupus erythematosus. Photodermatol Photoimmunol Photomed. 2013;29:4-11. doi:10.1111/phpp.12018
3.
FoeringKGoreshiRKleinRet al. Prevalence of self-report photosensitivity in cutaneous lupus erythematosus. J Am Acad Dermatol. 2012;66:220-228. doi:10.1016/j.jaad.2010.12.006
4.
VasquezRWangDTranQPet al. A multicentre, cross-sectional study on quality of life in patients with cutaneous lupus erythematosus. Br J Dermatol. 2013;168:145-153. doi:10.1111/j.1365-2133.2012.11106.x
5.
ScottFIMamtaniRBrensingerCMet al. Risk of nonmelanoma skin cancer associated with the use of immunosuppressant and biologic agents in patients with a history of autoimmune disease and nonmelanoma skin cancer. JAMA Dermatol. 2016;152:164-172. doi:10.1001/jamadermatol.2015.3029
6.
van den ReekJMPAvan LümigPPMJanssenMet al. Increased incidence of squamous cell carcinoma of the skin after long-term treatment with azathioprine in patients with auto-immune inflammatory rheumatic diseases. J Eur Acad Dermatol Venereol. 2014;28:27-33. doi:10.1111/jdv.12041
7.
LivingstonBBonnerAPopeJ.Differences in clinical manifestations between childhood-onset lupus and adult-onset lupus: a meta-analysis. Lupus. 2011;20:1345-1355. doi:10.1177/0961203311416694
8.
DoriaABiasinuttoCGhirardelloAet al. Photosensitivity in systemic lupus erythematosus: laboratory testing of ARA/ACR definition. Lupus. 1996;5:263-268. doi:10.1177/096120339600500404
9.
TsukazakiNWatanabeMShimizuKHamasakiYKatayamaI.Photoprovocation test and immunohistochemical analysis of inducible nitric oxide synthase expression in patients with Sjögren’s syndrome associated with photosensitivity. Br J Dermatol. 2002;147:1102-1108.
10.
AslanAKoturoğluGSözeriBKurugölZ.Systemic scleroderma in childhood: a case Report. Arch Rheumatol. 2014;29:219-223. doi:10.5606/ArchRheumatol.2014.3684
11.
LevyDMKamphuisS.Systemic lupus erythematosus in children and adolescents. Pediatr Clin North Am. 2012;59:345-364. doi:10.1016/j.pcl.2012.03.007
12.
SunCLeeJHYangYHet al. Juvenile dermatomyositis: a 20-year retrospective analysis of treatment and clinical outcomes. Pediatr Neonatol. 2015;56:31-39. doi:10.1016/j.pedneo.2014.02.006
13.
LoveLAWeinbergCRMcConnaugheyDRet al. Ultraviolet radiation intensity predicts the relative distribution of dermatomyositis and anti-Mi-2 autoantibodies in women. Arthritis Rheum. 2009;60:2499-2504. doi:10.1002/art.24702
14.
ShahMTargoffINRiceMMMillerFWRiderLG; Childhood Myositis Heterogeneity Collaborative Study Group. Brief report: ultraviolet radiation exposure is associated with clinical and autoantibody phenotypes in juvenile myositis. Arthritis Rheum. 2013;65:1934-1941. doi:10.1002/art.37985
15.
VegosenLJWeinbergCRO’HanlonTPTargoffINMillerFWRiderLG.Seasonal birth patterns in myositis subgroups suggest an etiologic role of early environmental exposures. Arthritis Rheum. 2007;56:2719-2728. doi:10.1002/art.22751
KuhnAGenschKHaustMet al. Photoprotective effects of a broad-spectrum sunscreen in ultraviolet-induced cutaneous lupus erythematosus: a randomized, vehicle-controlled, double-blind study. J Am Acad Dermatol. 2011;64:37-48. doi:10.1016/j.jaad.2009.12.053
18.
FurukawaFItohTWakitaHet al. Keratinocytes from patients with lupus erythematosus show enhanced cytotoxicity to ultraviolet radiation and to antibody-mediated cytotoxicity. Clin Exp Immunol. 1999;118:164-170.
19.
GolanTDElkonKBGharaviAEKruegerJG.Enhanced membrane binding of autoantibodies to cultured keratinocytes of systemic lupus erythematosus patients after ultraviolet B/ultraviolet A irradiation. J Clin Invest. 1992;90:1067-1076. doi:10.1172/JCI115922
20.
Casciola-RosenLRosenA.Ultraviolet light-induced keratinocyte apoptosis: a potential mechanism for the induction of skin lesions and autoantibody production in LE. Lupus. 1997;6:175-180. doi:10.1177/096120339700600213
21.
ZahnSGraefMPatsinakidisNet al. Ultraviolet light protection by a sunscreen prevents interferon-driven skin inflammation in cutaneous lupus erythematosus. Exp Dermatol. 2014;23:516-518. doi:10.1111/exd.12428
22.
KamphuisSSilvermanED. Prevalence and burden of pediatric-onset systemic lupus erythematosus. Nat Rev Rheumatol. 2010;6:538-546. doi:10.1038/nrrheum.2010.121
23.
RizwanMHaylettAKRichardsHLLingTCRhodesLE.Impact of photosensitivity disorders on the life quality of children. Photodermatol Photoimmunol Photomed. 2012;28:290-292. doi:10.1111/j.1600-0781.2012.00691.x
24.
MoorthyLNBaldinoMEKurraVet al. Relationship between health-related quality of life, disease activity and disease damage in a prospective international multicenter cohort of childhood onset systemic lupus erythematosus patients. Lupus. 2017;26:255-265. doi:10.1177/0961203316659546
25.
KostakiDAntoniniAPerisKFargnoliMC.Skin cancer risk in autoimmune connective tissue diseases. G Ital Dermatol Venereol. 2014;149:567-572.
26.
MaruGBGandhiKRamchandaniAKumarG.The role of inflammation in skin cancer. Adv Exp Med Biol. 2014;816:437-469. doi:10.1007/978-3-0348-0837-8_17
MannionMLBeukelmanT.What is the background incidence of malignancy in children with rheumatic disease?Curr Rheumatol Rep. 2013;15:310. doi:10.1007/s11926-012-0310-2
29.
DreyerLFaurschouMMogensenMJacobsenS.High incidence of potentially virus-induced malignancies in systemic lupus erythematosus: a long-term follow-up study in a Danish cohort. Arthritis Rheum. 2011;63:3032-3037. doi:10.1002/art.30483
30.
PuccioFB.Viruses as agents inducing cutaneous neoplasms [in Spanish]. Rev Peru Med Exp Salud Publica. 2013;30:79-84.
31.
BernatskySClarkeAELabrecqueJet al. Cancer risk in childhood-onset systemic lupus. Arthritis Res Ther. 2013;15:R198. doi:10.1186/ar4388
32.
AmaralBMurphyGIoannouYIsenbergDA.A comparison of the outcome of adolescent and adult-onset systemic lupus erythematosus. Rheumatology (Oxford). 2014;53:1130-1135. doi:10.1093/rheumatology/ket488
33.
Levy-ShragaYCohenRAmiMBYeshayahuYTemamVModan-MosesD.Sun exposure and protection habits in pediatric patients with a history of malignancy. PLoS One. 2015;10:e0137453. doi:10.1371/journal.pone.0137453
34.
MinaRBrunnerHI.Pediatric lupus—are there differences in presentation, genetics, response to therapy, and damage accrual compared with adult lupus?Rheum Dis Clin North Am. 2010;36:53-80. doi:10.1016/j.rdc.2009.12.012
35.
FogelALMiyarMTengJMC. Cutaneous malignancies in pediatric solid organ transplant recipients. Pediatr Dermatol. 2016;33:585-593. doi:10.1111/pde.12941
36.
ThakralAKlein-GitelmanMS.An update on treatment and management of pediatric systemic lupus erythematosus. Rheumatol Ther. 2016;3:209-219. doi:10.1007/s40744-016-0044-0
37.
ViláLMMayorAMValentínAHet al. Association of sunlight exposure and photoprotection measures with clinical outcome in systemic lupus erythematosus. P R Health Sci J. 1999;18:89-94.
38.
YangSYBernsteinILinDQet al. Photoprotective habits of patients with cutaneous lupus erythematosus. J Am Acad Dermatol. 2013;68:944-951. doi:10.1016/j.jaad.2012.11.016
39.
HonanAEBurfieldLHarkinsCPDrummondAFraserS.Variation in sun protection advice provided to those on immunosuppressants. J Am Acad Dermatol. 2015;72(5suppl 1):AB67. doi:10.1016/j.jaad.2015.02.277
40.
KuhnARulandVBonsmannG.Photosensitivity, phototesting, and photoprotection in cutaneous lupus erythematosus. Lupus. 2010;19:1036-1046. doi:10.1177/0961203310370344
41.
SurberCUlrichCHinrichsBStockflethE.Photoprotection in immunocompetent and immunocompromised people. Br J Dermatol. 2012;167(suppl 2):85-93. doi:10.1111/j.1365-2133.2012.11093.x
